Stay updated on Neratinib with Trastuzumab in ER+ HER2+ Breast Cancers Clinical Trial

Sign up to get notified when there's something new on the Neratinib with Trastuzumab in ER+ HER2+ Breast Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Neratinib with Trastuzumab in ER+ HER2+ Breast Cancers Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision history shows a new entry v3.4.1 added and the previous v3.4.0 removed; this reflects a minor version-control update with no visible changes to study data or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T23:55:59.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The history page adds a Show glossary option and clarifies color-coded changes; the revision label was updated from v3.3.4 to v3.4.0.
    Difference
    0.8%
    Check dated 2026-01-28T21:43:45.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    A new revision entry v3.3.4 was added to the record history, and the previous entry v3.3.3 was removed.
    Difference
    0.1%
    Check dated 2026-01-14T04:12:11.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Revision history shows the addition of Revision: v3.3.3 and the removal of HHS Vulnerability Disclosure as well as Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-23T22:40:57.000Z thumbnail image
  6. Check
    76 days ago
    Change Detected
    Summary
    Revision history now shows Revision: v3.3.2 as the latest entry, and Revision: v3.2.0 has been removed.
    Difference
    0.1%
    Check dated 2025-11-25T11:49:01.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Removed the banner warning about a lapse in government funding and potential downtime. The prior notice indicated that site information might not be up to date and that inquiries could be delayed.
    Difference
    0.6%
    Check dated 2025-11-18T07:15:21.000Z thumbnail image

Stay in the know with updates to Neratinib with Trastuzumab in ER+ HER2+ Breast Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Neratinib with Trastuzumab in ER+ HER2+ Breast Cancers Clinical Trial page.